Loading...
XSHE002014
Market cap815mUSD
Jan 10, Last price  
9.96CNY
1D
-3.21%
1Q
5.29%
Jan 2017
12.05%
Name

Huangshan Novel Co Ltd

Chart & Performance

D1W1MN
XSHE:002014 chart
P/E
14.66
P/S
1.77
EPS
0.68
Div Yield, %
0.00%
Shrs. gr., 5y
0.27%
Rev. gr., 5y
7.70%
Revenues
3.38b
+2.26%
485,083,912610,814,223718,899,0701,045,570,7371,219,428,1161,054,575,3421,276,392,2351,513,086,1271,521,013,2031,618,458,0511,668,452,2721,783,867,8011,904,193,7772,008,242,6052,332,267,5452,599,724,0412,737,497,3763,023,694,5513,304,135,2483,378,793,651
Net income
408m
+12.46%
43,680,91144,112,19347,255,23153,811,37168,050,165100,690,892121,235,153147,844,170178,770,833176,269,220154,491,070178,539,016202,710,560205,483,203225,324,381269,116,549303,032,141315,913,031362,828,955408,045,340
CFO
515m
-5.19%
48,299,76644,614,29064,806,47983,957,648151,200,923116,261,750125,460,797197,379,903185,638,196117,520,977187,818,118247,696,629280,628,298277,299,915323,833,456428,432,150548,623,540296,233,778543,555,266515,342,436
Dividend
Apr 12, 20240.55 CNY/sh
Earnings
Mar 21, 2025

Profile

Huangshan Novel Co., Ltd. manufactures and sells packaging materials primarily in China. The company's packaging materials include plastic color-printing, laminating flexible, vacuum metallized and multi-functional film, medical packaging, breathable and protective membrane, and injection molding materials. Its products are used in foodstuff, daily chemicals, pharmaceutical, agrochemicals, electronics, building materials, and other fields. The company also exports its products to Europe, the United States, Mexico, Japan, the Middle East, and rest of Asia. Huangshan Novel Co., Ltd. was founded in 1992 and is based in Huangshan, China.
URL
https://www.novel.com.cn/
IPO date
Jul 08, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,378,794
2.26%
3,304,135
9.27%
Cost of revenue
2,792,309
2,780,252
Unusual Expense (Income)
NOPBT
586,485
523,883
NOPBT Margin
17.36%
15.86%
Operating Taxes
46,764
38,937
Tax Rate
7.97%
7.43%
NOPAT
539,721
484,946
Net income
408,045
12.46%
362,829
14.85%
Dividends
(255,205)
Dividend yield
5.25%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
585,747
470,701
Long-term debt
114,050
45,666
Deferred revenue
37,602
45,786
Other long-term liabilities
773
(2,934)
Net debt
(579,391)
(696,356)
Cash flow
Cash from operating activities
515,342
543,555
CAPEX
(109,693)
Cash from investing activities
102,661
Cash from financing activities
(74,997)
121,728
FCF
580,351
318,264
Balance
Cash
1,479,901
1,212,723
Long term investments
(200,712)
1
Excess cash
1,110,249
1,047,516
Stockholders' equity
1,776,337
1,828,623
Invested Capital
2,075,956
1,811,444
ROIC
27.77%
27.96%
ROCE
18.40%
18.31%
EV
Common stock shares outstanding
609,023
604,715
Price
8.35
3.86%
8.04
12.45%
Market cap
5,085,341
4.60%
4,861,908
11.21%
EV
4,553,131
4,211,638
EBITDA
736,796
650,262
EV/EBITDA
6.18
6.48
Interest
20,266
13,198
Interest/NOPBT
3.46%
2.52%